Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation
Br J Anaesth
.
2014 Jul;113(1):194-5.
doi: 10.1093/bja/aeu217.
Authors
P Coriat
1
,
B Guidet
2
,
S de Hert
3
,
E Kochs
4
,
S Kozek
5
,
H Van Aken
6
;
all co-signatories listed online
Affiliations
1
Paris, France.
2
Saint Antoine, France.
3
Ghent, Belgium.
4
Munich, Germany.
5
Vienna, Austria.
6
Muenster, Germany hva@uni-muenster.de.
PMID:
24942721
DOI:
10.1093/bja/aeu217
No abstract available
Publication types
Letter
Comment
MeSH terms
Fluid Therapy / standards*
Humans
Hydroxyethyl Starch Derivatives / standards*
Plasma Substitutes / standards*
Resuscitation / standards*
Substances
Hydroxyethyl Starch Derivatives
Plasma Substitutes